case 8 Flashcards

1
Q

with SZ non adherence is predicted by

A

not seeing a medical benefit, not predicting relapse, not liking the medication, poor insight into their condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cognitive remediation

A

restorative or compensative. strategy based instructions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SZ

A

inc DA in nigrostriatal pathway. Knock on effects from abnormalities in glutamate or GABA systems. Dec DA in DLPFC. psychosis-loss contact with reality. hallucinations, delusions, dosorganised speech and behaviour, flattened effect, cog deficits, occupational social dysfunction. 1% prevalence. more common men. higher in lower socioeconomic classes. age onset 20-30 in woman, 15-25 men.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

dopamine

A

hormone-catecholamine and phenthylamine. motivation reward and reinforcement. tyrosine - tyrosine hydroxylase - LDOPA - DOPA decarboxylase - Dopamine. Reuptake Na ion dependent DA transporter DAT. MOA and COMT catabolise. Activate G protein coupled receptors. D1 type (D1 and D5) D2 type (D2,3,4). D1 coupled to G protein GSalpha activated adenylyl cyclase inc cAMP. D2 coupled G protein Gialpha inhibits formation cAMP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

nigrostriatal dopamine pathway

A

projects from substantia nigra to basal ganglia or striatum. Extrapyramidal nervous system. controls motor function and movement. hyperactivity is associated with pos symptoms, delusions and hallucinations. pleasure, hyperkinetic movement. SZ occurs in associative striatum of NS pathway. can be detected 3 yrs before first episode.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mesocortical dopamine pathway

A

from ventral tegmental area of brainstem to prefrontal cortex. cog symptoms in DLPFC, neg symptoms in DLPFC and VMPFC. deficit of DA. may be consequence of neurodevelopmental abnormalities in NMDA glutamate system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mesolimbic dopamine pathway

A

ventral tegmental area to limbic areas, mainly nucleus accumbens in ventral striatum. deficient in this area leads to anhedonia and lack of pleasure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

tuberoinfundibular dopamine pathway

A

from hypothalamus to anterior pituitary gland. inhibit prolactin release. When pregnant Da neurons dec so prolactin levels rise for breast feeding. This can occur with antipsychotics that block D2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 functional pathways of striatum

A

sensorimotor-input from SNc, D1/2 receptors. Associative-learning, memory, attention, emotion, input from DLPFC, DA from SNc. D1/2/3. Limbic-reward. DA from VTA. D1/2/3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

causes and risk factors

A

thought to have a biological basis as enlarged ventricles, thinning of cortex, dec hippocampus, changes in DA and glutamate. Genetic componant. environmental-stressers can cause reacurance but not causative. neurodevelopment vulnerability, substance abuse. cannabis doubles the risk. cocaine can give psychotic sympt.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

signs and symptoms

A

abnormal ideas-delusion. abnormal perceptions-hallucinations in all semses, auditory most prominent. motor and behavioural disorders-stereotypies(purposeless acts repetitivly) strange mannerisms, bizzare behaviour, catatonia, catalepsy(limbs can be manipulated) hyperactivity, impuslive behavious. thought disorders-unintelligible speech, neologism. emotional disorders-affective flattening, innapropriate affect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

types of delusions

A

persecution-somones trying to harm them. reference-everythings directed at and about them. control-something else is controling them. grandiose-divine purpose. hypochondrical-body is rotten. delusional mood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

positive symptoms

A

delusions, hallucinations, thought disorder, bizarre behavious. acute episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Negative symptoms

A

absence or reduction in normal function. apathy, affective blunting, poverty of speech, anhedonia, lack of desire for relationships, social withdrawl, avolition, impaired cog. chronic sympt.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

phases

A

premorbid-may show no symptoms. predromal-symptoms. middle phase, late illness phase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

viscious cycle

A

dec DA in DLPFC feedbacks to associative striatum to inc, inc in striatum fec in DLPFC. this is secondary to other dysfuntions of brain.

17
Q

glutamate hypothesis

A

diminished activation of NMDA receptors in brain. Phencyclidine caused hallucination and paranoia. PCP inhibits NMDA. low glutamate receptors found in SZ patients.

18
Q

types of SZ

A

paranoid-auditory hallucinations and delusions. Disorganised-disorganised thought processes, emotional effects. catatonic. Undifferentiated. Residual-when symptoms lessen.

19
Q

Diagnosis

A

DSM V, 2 or more of delusions hallucinations disorganised speech and behavious, neg symptoms. for 1 month, must include 1 of first 3.
ICD10 at least 1 first rank symptom for 1 month, thoughts delusions hallucinations. at least 2 second rank. Tests to rule out other causes of psychosis like substance abuse, mood disorders.

20
Q

cannabis

A

most widely abused drug, dried female flower cannabis sativa. contains psychoactive substances-THC. leads to dec BP blood shot eyes feeling dizzy inc appetite.

21
Q

cannabinoid receptors involved in psychosis

A

CB1 most effect of cannabinoids on CNS, appetite pain mood, euphoric and anticonvulsant. CB2 found in periphery expresed in immune system. activated by THC through production of endocannabinoid-anadamide.

22
Q

plant canabinoids THC and ligand anadamide

A

THC acts on reward system releasing dopamine. stim D2 receptors in striatum. Inc in release anandamide, activates cannabinoid receptors, euphoria. distort balance by binding CB1 in cerebellum and basal ganglia.

23
Q

endocannabinoids

A

substances produced in the brain. reduce the amount of neurotransmitter release. produced in post synaptic GABA neurons. GABA binds endocannabinoid source, production, bind CB1 cause reduction in GABA release, so less inhibit in brain cause euphoria. EC mediated depol induced suppression of inhibition.

24
Q

conventional antipsychotics

A

halperidone, chlorpromazine, fluphenazine. act primarily to block D2 but also block cholinergic histamine adrenergic and seratonin. high - low potency. high is most for D2, low is opposite. fatigue due H and A. extrapyramidal effects in nigrostriatal pathway-parkinsonism. akathisia. tardive dyskinesia. seizures. inc prolactin. hepatotoxicity. cardiovasc effects. weight gain, sexual dysfunction.

25
Q

risperidone

A

atypical 2nd gen antipsychotic. High affinity for seratonin in mesocortical (inc DA eliminate neg sympt) and D2 receptors in ventral part striatum (aleviates pos symptoms) not effect nigrostriatal so avoid extrapyramidal effects-happen at 78% occupancy. weight gain. neuroleptic malignant. syndrome. hyperprolactinemia happen at 72% occupancy. treatment begins to work when 60% occupancy.

26
Q

clozapine

A

given when 2 other AP fail. many SE like sedation hunger diabetes. binds best to D4.

27
Q

efficacy threshold

A

want 65% DA occupancy, typical have narrow dose range to overdose. atypical wider dose range.

28
Q

main SE

A

Major Side Effects of Antipsychotics

  • Elevated serum prolactin levels – antagonism of dopamine receptors in the tuberoinfundibular pathway
  • Parkinsonian symptoms – antagonism of dopamine receptors in the nigrostriatal pathway
  • Weight gain – antagonism of histamine H1 and serotonin 5-HT2c receptors plus effects on leptin
  • Deterioration in working memory – antagonism of dopamine receptors in the mesocortical pathway
  • Blurred near vision – antagonism of muscarinic M1 acetylcholine receptors
  • Sedation – antagonism of H1 and alpha-adrenergic receptors
29
Q

CB1 receptors

A

located on the presynaptic nerve terminals. anandamide and 2-arachidonoylglycerol (also stim CB2) activates it. linked to appetite.